Ellsworth Advisors, LLC Bristol Myers Squibb CO Transaction History

Ellsworth Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$63.71 - $70.74 $30,708 - $34,096	482 Added 4.75%	10,623 $679,000
Q1 2023 Apr 12, 2023	BUY	$65.71 - $74.53 $96,396 - $109,335	1,467 Added 16.91%	10,141 $702,000
Q4 2022 Jan 19, 2023	BUY	$68.48 - $81.09 $120,113 - $142,231	1,754 Added 25.35%	8,674 $0
Q3 2022 Oct 20, 2022	BUY	$0.13 - $76.84 $60 - $35,730	465 Added 7.2%	6,920 $492,000
Q2 2022 Jul 25, 2022	BUY	$72.62 - $79.98 $240,807 - $265,213	3,316 Added 105.64%	6,455 $497,000
Q1 2022 Apr 21, 2022	BUY	$61.48 - $73.72 $192,985 - $231,407	3,139 New	3,139 $243,000
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $198,633 - $232,673	-3,357 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$61.91 - $67.42 $3,838 - $4,180	-62 Reduced 1.81%	3,357 $224,000
Q1 2021 Apr 21, 2021	SELL	$59.34 - $66.74 $11,808 - $13,281	-199 Reduced 5.5%	3,419 $215,000
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $1,789 - $2,028	31 Added 0.86%	3,618 $224,000
Q2 2020 Feb 03, 2021	BUY	$54.82 - $64.09 $196,639 - $229,890	3,587 New	3,587 $211,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellsworth Advisors, LLC with notifications on news.